The Commonwealth Serum Laboratories was established in Australia in 1916 to service the health needs of a nation isolated by war. CSL Limited was then incorporated in 1991 and listed on the ASX in 1994.
Since then CSL acquired a number of companies including CSL Behring and Novartis’ influenza vaccine business.
CSL Behring can trace its corporate roots back to Emil von Behring, an innovator with serum therapies who won the first Nobel Prize in Physiology and Medicine.
The combined histories make CSL the innovative global company it is today.
We are proud to share our
history and our future with you.
CSL Centenary - 100 years timeline booklet and visit
CSL's Centenary website to learn about our past achievements.